• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzonitriles

Introduction to 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile (CAS No. 1345412-19-2)

4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile, identified by the Chemical Abstracts Service Number (CAS No.) 1345412-19-2, is a significant compound in the realm of pharmaceutical and chemical research. This molecule, featuring a benzonitrile core substituted with a 1H-imidazol-1-ylmethyl group, has garnered attention due to its potential applications in medicinal chemistry and drug development. The structural motif of this compound combines the versatility of the benzene ring with the unique electronic and steric properties of the imidazole ring, making it a promising candidate for further exploration.

The benzonitrile moiety is a well-documented pharmacophore in medicinal chemistry, often found in bioactive molecules due to its ability to interact with biological targets through hydrogen bonding and hydrophobic effects. In contrast, the 1H-imidazol-1-ylmethyl group introduces a nitrogen-rich heterocyclic structure, which is known for its role in modulating enzyme activity and receptor binding. The combination of these two structural elements in 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile suggests a multifaceted interaction potential with biological systems.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the binding affinities and mechanisms of action of such compounds more accurately. Studies have indicated that the presence of the imidazole ring can enhance the solubility and bioavailability of drug candidates, making 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile a valuable scaffold for designing novel therapeutic agents. Furthermore, the methyl substituent on the benzene ring may influence the electronic distribution and metabolic stability of the molecule, which are critical factors in drug design.

In vitro studies have begun to explore the pharmacological properties of 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile, revealing interesting interactions with various biological targets. For instance, preliminary data suggest that this compound may exhibit inhibitory effects on certain kinases and transcription factors, which are implicated in cancer and inflammatory diseases. The ability of the imidazole moiety to modulate protein-protein interactions has been particularly noteworthy, opening up avenues for developing targeted therapies.

The synthesis of 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile has been optimized through multiple routes, each offering distinct advantages in terms of yield, purity, and scalability. Modern synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions, have been employed to construct the core structure efficiently. These advances in synthetic chemistry have not only facilitated access to this compound but also provided insights into its structural diversity and functionalization possibilities.

One of the most compelling aspects of 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile is its potential as a building block for more complex derivatives. By introducing additional functional groups or modifying existing ones, researchers can tailor its pharmacological profile to meet specific therapeutic needs. For example, incorporating polar or charged moieties could enhance its binding affinity to certain receptors or improve its penetration across biological membranes.

The role of imidazole derivatives in medicinal chemistry cannot be overstated. These compounds have been extensively studied for their antimicrobial, antiviral, and anti-inflammatory properties. The structural similarity between imidazole and certain natural products has also inspired efforts to discover new bioactive molecules through computational screening and biosynthetic pathways. In this context, 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile represents an exciting opportunity for interdisciplinary research combining synthetic organic chemistry, computational biology, and pharmacology.

As our understanding of disease mechanisms continues to evolve, so does the demand for innovative therapeutic strategies. Compounds like 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile hold promise for addressing unmet medical needs by targeting key pathways involved in human health and disease. The integration of cutting-edge technologies such as high-throughput screening (HTS) and structure-based drug design (SBDD) will further accelerate the discovery process.

The future directions for research on 4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile include exploring its pharmacokinetic properties, conducting preclinical studies to assess its safety and efficacy, and developing novel formulations for improved delivery. Collaborative efforts between academic institutions and pharmaceutical companies will be essential in translating laboratory findings into tangible benefits for patients worldwide.

In conclusion,4-(1H-imidazol-1-yl)methyl-2-methylbenzonitrile (CAS No. 1345412-19-2) is a structurally intriguing compound with significant potential in pharmaceutical research. Its unique combination of chemical features positions it as a valuable tool for developing new drugs targeting various diseases. As scientific knowledge advances and new methodologies emerge,this molecule is poised to play an important role in shaping the future of medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)